Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven E Shoelson

Showing results (31-40 of 61) with videos related to

Pageof 7
Sort By:
Critical Care Medicine|June 17, 2014
Muscle-specific inhibition of the classical nuclear factor-κB pathway is protective against diaphragmatic weakness in murine endotoxemiaTatsuma Okazaki, Feng Liang, Tong Li, et al.
International Journal of Biological Macromolecules|May 27, 2017
The carboxy-terminal region of the TBC1D4 (AS160) RabGAP mediates protein homodimerizationJu Rang Woo, Soon-Jong Kim, Keon Young Kim, et al.
Nature Medicine|February 3, 2005
Local and systemic insulin resistance resulting from hepatic activation of IKK-beta and NF-kappaBDongsheng Cai, Minsheng Yuan, Daniel F Frantz, et al.
Molecular Cell|November 28, 2002
Diabetes mutations delineate an atypical POU domain in HNF-1alphaYoung-In Chi, J Daniel Frantz, Byung-Chul Oh, et al.
Nature|June 23, 2012
PPAR-γ is a major driver of the accumulation and phenotype of adipose tissue Treg cellsDaniela Cipolletta, Markus Feuerer, Amy Li, et al.
Diabetes Care|November 21, 2013
The impact of salsalate treatment on serum levels of advanced glycation end products in type 2 diabetesJoshua I Barzilay, Kathleen A Jablonski, Vivian Fonseca, et al.
The Journal of Biological Chemistry|December 21, 2002
Grb10 inhibits insulin-stimulated insulin receptor substrate (IRS)-phosphatidylinositol 3-kinase/Akt signaling pathway by disrupting the association of IRS-1/IRS-2 with the insulin receptorKeriLyn R Wick, Eric D Werner, Paul Langlais, et al.
Diabetes, Obesity & Metabolism|March 16, 2017
Salsalate improves glycaemia in overweight persons with diabetes risk factors of stable statin-treated cardiovascular disease: A 30-month randomized placebo-controlled trialNinad Salastekar, Tanvi Desai, Thomas Hauser, et al.
The Journal of Clinical Investigation|May 22, 2002
Mechanism by which high-dose aspirin improves glucose metabolism in type 2 diabetesRipudaman S Hundal, Kitt F Petersen, Adam B Mayerson, et al.
Annals of Internal Medicine|July 3, 2013
Salicylate (salsalate) in patients with type 2 diabetes: a randomized trialAllison B Goldfine, Vivian Fonseca, Kathleen A Jablonski, et al.
Pageof 7

Showing results (31-40 of 61) with videos related to

Sort By:
Pageof 7
Critical Care Medicine|June 17, 2014
Muscle-specific inhibition of the classical nuclear factor-κB pathway is protective against diaphragmatic weakness in murine endotoxemiaTatsuma Okazaki, Feng Liang, Tong Li, et al.
International Journal of Biological Macromolecules|May 27, 2017
The carboxy-terminal region of the TBC1D4 (AS160) RabGAP mediates protein homodimerizationJu Rang Woo, Soon-Jong Kim, Keon Young Kim, et al.
Nature Medicine|February 3, 2005
Local and systemic insulin resistance resulting from hepatic activation of IKK-beta and NF-kappaBDongsheng Cai, Minsheng Yuan, Daniel F Frantz, et al.
Molecular Cell|November 28, 2002
Diabetes mutations delineate an atypical POU domain in HNF-1alphaYoung-In Chi, J Daniel Frantz, Byung-Chul Oh, et al.
Nature|June 23, 2012
PPAR-γ is a major driver of the accumulation and phenotype of adipose tissue Treg cellsDaniela Cipolletta, Markus Feuerer, Amy Li, et al.
Diabetes Care|November 21, 2013
The impact of salsalate treatment on serum levels of advanced glycation end products in type 2 diabetesJoshua I Barzilay, Kathleen A Jablonski, Vivian Fonseca, et al.
The Journal of Biological Chemistry|December 21, 2002
Grb10 inhibits insulin-stimulated insulin receptor substrate (IRS)-phosphatidylinositol 3-kinase/Akt signaling pathway by disrupting the association of IRS-1/IRS-2 with the insulin receptorKeriLyn R Wick, Eric D Werner, Paul Langlais, et al.
Diabetes, Obesity & Metabolism|March 16, 2017
Salsalate improves glycaemia in overweight persons with diabetes risk factors of stable statin-treated cardiovascular disease: A 30-month randomized placebo-controlled trialNinad Salastekar, Tanvi Desai, Thomas Hauser, et al.
The Journal of Clinical Investigation|May 22, 2002
Mechanism by which high-dose aspirin improves glucose metabolism in type 2 diabetesRipudaman S Hundal, Kitt F Petersen, Adam B Mayerson, et al.
Annals of Internal Medicine|July 3, 2013
Salicylate (salsalate) in patients with type 2 diabetes: a randomized trialAllison B Goldfine, Vivian Fonseca, Kathleen A Jablonski, et al.
Pageof 7